Meeting
2023 ASCO Annual Meeting
Socio-demographic, clinical, and genetic predictors of low versus high Gleason score among men with prostate cancer in the Detroit Research on Cancer Survivorship (ROCS) cohort.
Authors
Samantha Goodenow
Wayne State University School of Medicine, Detroit, MI
Samantha Goodenow , Frank Cameron Cackowski , Elisabeth I. Heath , Julie J. Ruterbusch , Greg Dyson , Jennifer Lynn Beebe-Dimmer , Michael S. Simon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer–Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5092)
DOI
10.1200/JCO.2023.41.16_suppl.5092
Abstract #
5092
Poster Bd #
186
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic castration-sensitive prostate cancer: A pooled analysis of the STOMP and ORIOLE trials.
First Author: Mathew Pierre Deek
Poster
2022 ASCO Genitourinary Cancers Symposium
Correlation of the rate of metastasis-free survival with the presence of pathogenic germline genetic mutations in patients with prostate cancer at a community practice.
First Author: Siddharth Ramanathan
Poster
2015 Genitourinary Cancers Symposium
Germ line predictors of response to androgen deprivation therapy in men with advanced prostate cancer.
First Author: Neeraj Agarwal
Poster
2023 ASCO Genitourinary Cancers Symposium
Prospective validation of single nucleotide polymorphisms as predictors of gastrointestinal, genitourinary, and sexual toxicities following radiation therapy for prostate cancer.
First Author: Sophia C. Kamran